Sexual side effects added to Merck drug labels

(Reuters) - Prescribing labels for Merck & Co's drugs for baldness and enlarged prostate will add reports of sexual side effects that continued after use of the medicines was stopped, U.S. health regulators said. Labels will be revised for Proscar, which treats symptoms of enlarged prostate, and hair-loss treatment Propecia, the Food and Drug Administration said. The active ingredient in both drugs is finasteride. The Propecia label will now include notification of problems with libido, ejaculation and orgasms that continued after use of the drug was ended. ...

FDA revokes approval of Avastin for breast cancer (AP)

AP - The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer.